Top-News
Professionelle Dienstleistungen USA

Verve Therapeutics News

Aktie
WKN:  A3CSHT ISIN:  US92539P1012 US-Symbol:  VERV
5,14 $
+0,02 $
+0,39%
31.05.24 21:48:50
Handeln Depot/Watchlist
Aktienanzahl *
63,72 Mio.
Marktkapitalisierung *
305,42 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 31.10.2023

Verve Therapeutics News

19.04.24 - PR Newswire
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws PR Newswire
27.11.23 - PR Newswire
Thinking about trading options or stock in Shopify, Novo Nordisk, Verve Therapeutics, Cerence, or Exxon Mobil?
Thinking about trading options or stock in Shopify, Novo Nordisk, Verve Therapeutics, Cerence, or Exxon Mobil? PR Newswire
08.11.23 - wallstreet:online Zentralredaktion
Neben Coinbase und DraftKings: Cathie Woods beste Woche aller Zeiten: Diese Top-Wette hat sie jetzt verkauft
Der Ark Innovation ETF (ARKK) von Cathie Wood übertrifft den Gesamtmarkt in der Regel sowohl nach oben als auch nach unten. In der letzten Woche verzeichnete der Flagship ...
07.11.23 - wallstreet:online Zentralredaktion
Neben Coinbase und DraftKings: Cathie Wood: Beste Woche aller Zeiten – diese Top-Wette hat sie jetzt verkauft
Der Ark Innovation ETF (ARKK) von Cathie Wood übertrifft den Gesamtmarkt in der Regel sowohl nach oben als auch nach unten. In der letzten Woche verzeichnete der Flagship ...
15.06.23 - PR Newswire
Thinking about buying stock in Bentley Systems, MicroStrategy, Icahn Enterprises, Verve Therapeutics, or Bilibili?
Thinking about buying stock in Bentley Systems, MicroStrategy, Icahn Enterprises, Verve Therapeutics, or Bilibili? PR Newswire
04.01.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire
19.12.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire
12.12.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire
05.12.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire
21.11.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire
14.11.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire
25.08.22 - PR Newswire
Thinking about buying stock in Alaunos Therapeutics, BioSig Technologies, Futu Holdings, Hall of Fame Resort & Entertainment, or Verve Therapeutics?
Thinking about buying stock in Alaunos Therapeutics, BioSig Technologies, Futu Holdings, Hall of Fame Resort & Entertainment, or Verve Therapeutics? PR Newswire
13.07.22 - Der Aktionär
CRISPR‑Aktien im Rallymodus: Intellia, Editas Medicine und Co starten durch

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »